Cholestech gets Mexican screening deal:
This article was originally published in Clinica
California firm Cholestech has won a contract from the Mexican government to conduct cholesterol screening of all workers that operate public transport. The agreement is to supply the communications and transport ministry with the Cholestech LDX system - initially 42 units. This will be done through the company's Mexico City-based distributor, Nutritional Science and Technology (NST). The Mexican government decided on the LDX after the success of a six-month pilot. The system can test at point-of-care for cholesterol, blood glucose, liver enzymes, ALT and AST, and high-sensitivity C-reactive protein. Mexico performs comprehensive healthcare screening of more than 100,000 transport workers per year. The Hayward, California company says it is in discussions with other government departments to expand the programme.
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
While analysts are struggling to look further than generic competition facing the French firm's best-seller Somatuline, new chief David Loew tells Scrip that intelligent lifecycle management and focused external deals will drive Ipsen's growth.
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.